Aliases & Classifications for Synovitis

Summaries for Synovitis

Disease Ontology : 12 A connective tissue disease that results_in inflammation located in synovial membrane that lines a synovial joint which causes pain and swelling.

MalaCards based summary : Synovitis is related to pigmented villonodular synovitis and villonodular synovitis, and has symptoms including arthralgia, metatarsalgia and myalgia. An important gene associated with Synovitis is TNF (Tumor Necrosis Factor). The drugs Bevacizumab and Etanercept have been mentioned in the context of this disorder. Affiliated tissues include bone, t cells and bone marrow.

Wikipedia : 72 Synovitis is the medical term for inflammation of the synovial membrane. This membrane lines joints that... more...

Related Diseases for Synovitis

Graphical network of the top 20 diseases related to Synovitis:



Diseases related to Synovitis

Symptoms & Phenotypes for Synovitis

UMLS symptoms related to Synovitis:


arthralgia, metatarsalgia, myalgia

Drugs & Therapeutics for Synovitis

Drugs for Synovitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 175)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bevacizumab Approved, Investigational Phase 4 216974-75-3
2
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2 185243-69-0
3
Methotrexate Approved Phase 4,Phase 3,Phase 2 1959-05-2, 59-05-2 126941
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 83-43-2 6741
5
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 50-24-8 5755
6
Infliximab Approved Phase 4,Phase 2 170277-31-3
7
Hydroxychloroquine Approved Phase 4,Phase 2 118-42-3 3652
8
Menthol Approved Phase 4,Early Phase 1 2216-51-5 16666
9
Sulfasalazine Approved Phase 4 599-79-1 5353980 5359476
10
rituximab Approved Phase 4,Phase 3,Phase 2 174722-31-7 10201696
11
Certolizumab pegol Approved Phase 4,Phase 3 428863-50-7
12
Adalimumab Approved Phase 4,Phase 2 331731-18-1 16219006
13
Triamcinolone Approved, Vet_approved Phase 4,Phase 2 124-94-7 31307
14
Abatacept Approved Phase 4,Phase 3,Phase 2,Phase 1 332348-12-6 10237
15
Leflunomide Approved, Investigational Phase 4,Phase 3 75706-12-6 3899
16
Apremilast Approved, Investigational Phase 4,Phase 2 608141-41-9 11561674
17
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
18
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 59-30-3 6037
19
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2 58-05-9 143 6006
20 Angiogenesis Inhibitors Phase 4,Phase 2
21 Angiogenesis Modulating Agents Phase 4,Phase 2
22 Analgesics Phase 4,Phase 3,Phase 2
23 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2
24 Antibodies Phase 4,Phase 3,Phase 2,Phase 1
25 Antiemetics Phase 4,Phase 3,Phase 2,Early Phase 1
26 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Early Phase 1
27 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 2
28 Antimetabolites Phase 4,Phase 3,Phase 2
29 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2
30 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Early Phase 1
31 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
32 Autonomic Agents Phase 4,Phase 3,Phase 2,Early Phase 1
33 Dermatologic Agents Phase 4,Phase 3,Phase 2
34 Folic Acid Antagonists Phase 4,Phase 3,Phase 2
35 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Early Phase 1
36 glucocorticoids Phase 4,Phase 3,Phase 2,Early Phase 1
37 Hormone Antagonists Phase 4,Phase 3,Phase 2,Early Phase 1
38 Hormones Phase 4,Phase 3,Phase 2,Early Phase 1
39 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Early Phase 1
40 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1
41 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
42 Methylprednisolone acetate Phase 4,Phase 3,Phase 2,Early Phase 1
43 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Phase 2,Early Phase 1
44 Neuroprotective Agents Phase 4,Phase 3,Phase 2,Early Phase 1
45 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2
46 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Early Phase 1
47 Prednisolone acetate Phase 4,Phase 3,Phase 2,Early Phase 1
48 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2,Early Phase 1
49 Prednisolone phosphate Phase 4,Phase 3,Phase 2,Early Phase 1
50 Protective Agents Phase 4,Phase 3,Phase 2,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 149)

id Name Status NCT ID Phase Drugs
1 Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis Unknown status NCT02060305 Phase 4 Bevacizumab intra-articular injection
2 Targeting Synovitis in Early Rheumatoid Arthritis Unknown status NCT00920478 Phase 4
3 Remission Induction in Very Early Rheumatoid Arthritis Unknown status NCT00523692 Phase 4 Etanercept, methotrexate and depomedrone;depemedrone
4 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Unknown status NCT01282528 Phase 4
5 Very Early Versus Delayed Etanercept in Patients With RA Unknown status NCT02433184 Phase 4 Etanercept;Methotrexate;Sulfasalazine;Hydroxychloroquine;Etanercept;Methotrexate
6 A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs Completed NCT01034397 Phase 4 tocilizumab [RoActemra/Actemra];placebo;non-biological DMARDs
7 A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis. Completed NCT00502853 Phase 4 rituximab [MabThera/Rituxan];Methotrexate
8 A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study Completed NCT00396747 Phase 4 Infliximab, methylprednisolone, methotrexate;Methotrexate;Methotrexate + Methylprednisolone;Methotrexate + Infliximab
9 Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA) Completed NCT01098201 Phase 4 Certolizumab
10 Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab Completed NCT01717859 Phase 4 Tocilizumab
11 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Completed NCT01205854 Phase 4
12 Bone Mineral Density Changes Under Two Tibial Components in Total Knee Arthroplasty Completed NCT01764984 Phase 4
13 Prednisolone for Pain Reduction in Knee OA Completed NCT01619163 Phase 4 Placebo;Prednisolone
14 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis Completed NCT00420927 Phase 4 methotrexate
15 Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic Polyarthritis Recruiting NCT02437461 Phase 4 Triamcinolone hexacetonide
16 Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis Recruiting NCT02765074 Phase 4 subcutaneous tocilizumab
17 The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients Active, not recruiting NCT01948388 Phase 4 corticotrophin 80 units
18 A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA) Active, not recruiting NCT02198651 Phase 4 Adalimumab
19 The Comparative Study of Intra-articular Injection of Tocilizumab and Compound Betamethasone Not yet recruiting NCT03215407 Phase 4 Intra-articular Tocilizumab;Intra-articular Compound Betamethasone
20 Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders Not yet recruiting NCT03227419 Phase 4 Tocilizumab Prefilled Syringe;Abatacept Prefilled Syringe
21 Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study Terminated NCT01659242 Phase 4 Methotrexate plus sulfasalazine;Leflunomide
22 A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR) Terminated NCT01117129 Phase 4 rituximab [MabThera/Rituxan];placebo;methotrexate;rituximab [Mabthera/Rituxan]
23 A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs Withdrawn NCT01878318 Phase 4 methotrexate;tocilizumab [RoActemra/Actemra]
24 Treatment With Apremilast in Patients With Psoriatic Arthritis Withdrawn NCT02558361 Phase 4 Treatment with Apremilast
25 The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients Completed NCT01213017 Phase 3 certolizumab pegol
26 Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee Completed NCT00604539 Phase 3 Chondroitin sulphate (Condrosan);Placebo
27 Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study Completed NCT00522184 Phase 3
28 A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs Completed NCT00996606 Phase 3 DMARDs;Tocilizumab
29 A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Completed NCT00420199 Phase 3 Abatacept;Placebo
30 A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography Completed NCT00767325 Phase 3 Abatacept;Methotrexate
31 Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever Completed NCT01705756 Phase 3 Kineret
32 Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? Completed NCT02164214 Phase 3 etanercept Treatment
33 Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA) Completed NCT01235598 Phase 3
34 TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNF Completed NCT00977106 Phase 3 tocilizumab [RoActemra/Actemra];placebo;tocilizumab [RoActemra/Actemra]
35 A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate Completed NCT00578305 Phase 3 Placebo;Methylprednisolone;Methotrexate;Folic acid or folate
36 An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Completed NCT01951170 Phase 3 Tocilizumab
37 A Study Of RoActemra/Actemra (Tocilizumab) in Tocilizumab-Naive Patients With Rheumatoid Arthritis With Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) or Biologic Therapy Completed NCT02001987 Phase 3 tocilizumab [RoActemra/Actemra]
38 Colchicine for Symptom and Inflammation in Knee Osteoarthritis Completed NCT02176460 Phase 2, Phase 3 Colchicine;Placebo
39 Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis Completed NCT01244958 Phase 3 Placebo
40 Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) Recruiting NCT02662985 Phase 3 AIN457 (secukinumab);Placebo
41 Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia Recruiting NCT02778906 Phase 3 Abatacept;Placebo
42 Multicentre Canadian Study to Measure the Safety and Efficacy of Radiosynoviorthesis Recruiting NCT01615991 Phase 3 Radiosynoviorthesis
43 Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders Recruiting NCT02266433 Phase 3 Ketorolac;Dexamethasone
44 PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) Active, not recruiting NCT02371369 Phase 3 PLX3397 capsule;Placebo capsule matching PLX3397 capsule
45 An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective Active, not recruiting NCT02566967 Phase 3 tofacitinib
46 Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements Unknown status NCT01272830 Phase 2 Placebo;Apatone®B
47 Knee Osteoarthritis AND Methotrexate Use Unknown status NCT01927484 Phase 2 25 mg/week oral methotrexate tablets;25mg/week oral placebo tablets
48 Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) Completed NCT01261429 Phase 2 Tasigna
49 Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis Completed NCT00678782 Phase 2 etanercept;placebo
50 Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy Completed NCT00001677 Phase 2 Methotrexate;Fludarabine

Search NIH Clinical Center for Synovitis

Cochrane evidence based reviews: synovitis

Genetic Tests for Synovitis

Genetic tests related to Synovitis:

id Genetic test Affiliating Genes
1 Synovitis 29

Anatomical Context for Synovitis

MalaCards organs/tissues related to Synovitis:

39
Bone, T Cells, Bone Marrow, Endothelial, Liver, Neutrophil, B Cells

Publications for Synovitis

Articles related to Synovitis:

(show top 50) (show all 1259)
id Title Authors Year
1
Level of agreement between three-dimensional volumetric ultrasound and real-time conventional ultrasound in the assessment of synovitis, tenosynovitis and erosions in rheumatoid arthritis patients. ( 27896420 )
2017
2
Could autophagy induced by misfolded mutant alpha-1-antitrypsin Z in synovitis explain the association of ATZ with increased ACPA production in RA? ( 28881422 )
2017
3
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. ( 28081709 )
2017
4
Ratiometric Optical Imaging of Subclinical Inflammation with a Thrombin-cleavable Probe: A Future Tool for the In Vivo Visualization of Clinically Silent Synovitis? ( 28898572 )
2017
5
A case of bronchiolitis obliterans organising pneumonia associated with SAPHO (synovitis-acne-pustulosis-hyperostosis-osteitis) syndrome. ( 28765183 )
2017
6
Localized pigmented villonodular synovitis of the ankle: Expect the unexpected. ( 28159047 )
2017
7
Para-articular extraskeletal chondroma mimicking first metatarsophalangeal synovitis. ( 28828128 )
2017
8
Multifocal pigmented villonodular synovitis coexisting in both the knee joint and the patella: a case report and literature review. ( 28683727 )
2017
9
An unusual case of diffuse pigmented villonodular synovitis of the shoulder: A multidisciplinary approach with arthroscopic synovectomy and adjuvant radiotherapy. ( 28638690 )
2017
10
Pigmented villonodular synovitis of the knee: A retrospective analysis of 214 cases at a UK tertiary referral centre. ( 28442184 )
2017
11
Localized pigmented villonodular synovitis in a child knee. ( 28291439 )
2017
12
SOCS3 participates in cholinergic pathway regulation of synovitis in rheumatoid arthritis. ( 28914550 )
2017
13
Diffuse Pigmented Villonodular Synovitis as a Rare Cause of Graft Failure Following Anterior Cruciate Ligament Reconstruction. ( 28776631 )
2017
14
Platelet-rich plasma intra-articular injections for haemophilic synovitis: Scientific knowledge does not support its use. ( 28840633 )
2017
15
Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system. ( 28948983 )
2017
16
Functional complement activity is decisive for the development of chronic synovitis, osteophyte formation and processes of cell senescence in zymosan-induced arthritis. ( 28860038 )
2017
17
Associations Between Knee Effusion-synovitis and Joint Structural Changes in Patients with Knee Osteoarthritis. ( 28864651 )
2017
18
Pigmented Villonodular Synovitis of the Temporomandibular Joint With Petrous Bone Invasion. ( 28333775 )
2017
19
Intra-articular Localized Haemangioma of the Knee Mimicking Localized Pigmented Villonodular Synovitis: A Case Report. ( 28435577 )
2017
20
A simplified and validated ultrasound scoring system to evaluate synovitis of bilateral wrists and hands in patients with rheumatoid arthritis. ( 28831575 )
2017
21
Diffuse pigmented villonodular synovitis in knee joint: diagnosis and treatment. ( 28884104 )
2017
22
Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. ( 28948984 )
2017
23
Pigmented Villonodular Synovitis of Thumb-A Cytological Diagnosis. ( 28764182 )
2017
24
SAPHO Syndrome: Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis. ( 28250311 )
2017
25
Open and Arthroscopic with Mini-Open Surgical Hip Approaches for Treatment of Pigmented Villonodular Synovitis and Concomitant Hip Pathology. ( 28326214 )
2017
26
The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis - a cohort study. ( 28086960 )
2017
27
With a biomechanical treatment in knee osteoarthritis, less knee pain did not correlate with synovitis reduction. ( 28797238 )
2017
28
Flexor Hallucis Longus Tenosynovitis and First Metatarsophalangeal Synovitis After Penetrating Nail Prick Injury: Treated by Zone 3 Flexor Hallucis Longus Tendoscopy and Metatarsosesamoid Arthroscopy. ( 28580263 )
2017
29
Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). ( 28057477 )
2017
30
Is synovitis detected on non-contrast-enhanced magnetic resonance imaging associated with serum biomarkers and clinical signs of effusion? Data from the Osteoarthritis Initiative. ( 28929915 )
2017
31
Long-term outcome of knee arthroplasty in the setting of pigmented villonodular synovitis. ( 28552192 )
2017
32
Hereditary hemochromatosis arthropathy and Doppler ultrasound findings of synovitis. ( 28371912 )
2017
33
Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) Syndrome with Significant Bilateral Pleural Effusions. ( 28924111 )
2017
34
Localized pigmented villonodular synovitis of posterior compartment of the knee. ( 28847242 )
2017
35
Association of Chondrocalcinosis in Knee Joints With Pain and Synovitis: Data From the Osteoarthritis Initiative. ( 28129488 )
2017
36
Pigmented Villonodular Synovitis - Various Manifestations, Inconsistent Terminology and Treatment. Cases Study. ( 28436371 )
2017
37
Feasibility of photoacoustic/ultrasound imaging of synovitis in finger joints using a point-of-care system. ( 28913168 )
2017
38
Frondlike Synovitis on MRI and Correlation With Polyethylene Surface Damage of Total Knee Arthroplasty. ( 28777663 )
2017
39
PIGMENTED VILLONODULAR SYNOVITIS IN A RETICULATED GIRAFFE (GIRAFFA CAMELOPARDALIS). ( 28749260 )
2017
40
Results and recurrence of pigmented villonodular synovitis of the ankle: does diffuse PVNS with extra-articular extension tend to recur more often? ( 28389877 )
2017
41
Locked hip joint: an uncommon presentation of localized pigmented villonodular synovitis. ( 27130398 )
2016
42
Active Foot Synovitis in Patients with Rheumatoid Arthritis: Patients with Foot Synovitis in Apparent Remission have Unstable Remission Status, Radiographic Progression and Worse Functional Outcomes. ( 26991415 )
2016
43
Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Associated with Myeloma and Syndrome of Inappropriate Antidiuretic Hormone Secretion in an Elderly Man. ( 27550802 )
2016
44
Evidence of response to IL-6 inhibition in some cases of refractory spondyloarthritis-associated peripheral synovitis. ( 27059696 )
2016
45
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques. ( 27002108 )
2016
46
Pigmented villonodular synovitis of the hip. ( 28461957 )
2016
47
Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis. ( 27499236 )
2016
48
Chronic Synovitis after Open Carpal Tunnel Decompression. ( 27454645 )
2016
49
Imaging for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome. ( 27742022 )
2016
50
Ultrasound power Doppler synovitis is associated with plasma IL-6 in established rheumatoid arthritis. ( 27026419 )
2016

Variations for Synovitis

Expression for Synovitis

Search GEO for disease gene expression data for Synovitis.

Pathways for Synovitis

GO Terms for Synovitis

Sources for Synovitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....